Your browser doesn't support javascript.
loading
Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials.
Ledenko, Matthew; Antwi, Samuel O; Arima, Shiho; Driscoll, Julia; Furuse, Junji; Klümpen, Heinz-Josef; Larsen, Finn Ole; Lau, David K; Maderer, Annett; Markussen, Alice; Moehler, Markus; Nooijen, Lynn E; Shaib, Walid L; Tebbutt, Niall C; André, Thierry; Ueno, Makoto; Woodford, Rachel; Yoo, Changhoon; Zalupski, Mark M; Patel, Tushar.
Afiliación
  • Ledenko M; Department of Transplantation, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, United States.
  • Antwi SO; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, United States.
  • Arima S; Department of Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
  • Driscoll J; Department of Transplantation, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, United States.
  • Furuse J; Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan.
  • Klümpen HJ; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Center (UMC), Amsterdam, Netherlands.
  • Larsen FO; Department of Oncology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark.
  • Lau DK; Oncogenic Transcription Laboratory, Olivia Newton-John Cancer and Research Institute, Melbourne, VIC, Australia.
  • Maderer A; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia.
  • Markussen A; First Department of Medicine, University Medical Center of the Johannes-Gutenberg University, Mainz, Germany.
  • Moehler M; Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
  • Nooijen LE; Department of Oncology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark.
  • Shaib WL; First Department of Medicine, University Medical Center of the Johannes-Gutenberg University, Mainz, Germany.
  • Tebbutt NC; Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
  • André T; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.
  • Ueno M; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, United States.
  • Woodford R; Department of Medical Oncology, Olivia Newton-John Cancer Centre at Austin Health, Heidelberg, VIC, Australia.
  • Yoo C; Sorbonne University and Department of Medical Oncology, Hôpital Saint-Antoine, AP-HP, Paris, France.
  • Zalupski MM; Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Kanagawa, Japan.
  • Patel T; National Health and Medical Research Council Clinical Trials Centre (NHMRC CTC), Medical Foundation Building, University of Sydney, Camperdown, NSW, Australia.
Front Oncol ; 12: 963753, 2022.
Article en En | MEDLINE | ID: mdl-36033540
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos